Dr Reddy's shares fall due to semaglutide supply issues
India's Dr Reddy's Laboratories is experiencing its worst trading day in three years following disruptions in the supply of semaglutide.
Results for "Dr Reddy's Laboratories"
3 stories found
Novo Nordisk Sues Dr Reddy's Over Ozempic Trademark Infringement
Novo Nordisk has initiated legal action against India's Dr Reddy's Laboratories concerning a trademark dispute involving its popular drug Ozempic and Dr Reddy's product Olymviq.
Indian High Court Rejects Novo Nordisk Plea Against Dr Reddy's Ozempic-like Drug
The Indian High Court has dismissed an appeal by Novo Nordisk seeking to prevent Dr Reddy's Laboratories from manufacturing and exporting an Ozempic-like drug, allowing the Indian firm to proceed.